Eagle Pharmaceuticals Inc Revenue per Employee (EGRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eagle Pharmaceuticals inc   (NASDAQ: EGRX)
 

Eagle Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Eagle Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 2,201,291, below the company average number of $800,246.
Within the Healthcare sector Employees of 58 other companies have achieved higher revenue per employee. While Eagle Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 534 to 657. Eagle Pharmaceuticals Inc has 117 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EGRX Revenue per Employee (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Revenue Change -12.8 % -42.78 % 43.43 % 65.36 % 54.05 %
Sales per Employee (TTM) $ 2,201,291 2,282,402 2,706,068 2,548,983 2,326,350
EGRX's Total Ranking # 657 # 534 # 0 # 0 # 0
Seq. Revenue Change -2.5 % 9.24 % -7.89 % -11.11 % -36.02 %

EGRX Company Profile >> Back to EGRX Efficiency Comparisons >> Compare EGRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 31
Healthcare Sector # 59
Overall Market # 657

Revenue per Employee Statistics
High Average Low
$ 1,213,065 $ 800,246 $ 228,004
(Dec 31 2022)   (March 31, 2016)



Financial Statements
Eagle Pharmaceuticals Inc 's Revenue MRQ $ 65 Millions Visit EGRX's Income Statement
Eagle Pharmaceuticals Inc 's Revenues TTM $ 258 Millions Visit EGRX's aggregate revenue growth
What are EGRX's Sales? Visit EGRX's Sales by Segment




Other Ratios
Eagle Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EGRX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EGRX's Competitors
Revenue per Employee for EGRX's Suppliers
Revenue per Employee for EGRX's Customers

You may also want to know
EGRX's Sales Growth Rates EGRX's Pe Price to earnings ratio EGRX's Receivables Turnover Ratio EGRX's Stock Quote
EGRX's Net Income Growth Rates EGRX's Ps Price to Sales ratio EGRX's Sales per Employee EGRX's Asset Turnover Ratio
EGRX's Net Margin EGRX's Pb Price to Book ratio EGRX's Financial Strength Ratios EGRX's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:01+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2023Number of Employees Jun 30 2023
P3 Health Partners Inc   3,555,111.55 $ 1,137.636  Million 320 
Illumina Inc   3,485,937.50 $ 4,462.000  Million 1,280 
Ligand Pharmaceuticals Incorporated  3,478,255.32 $ 163.478  Million 47 
Pulmatrix Inc   3,461,500.00 $ 6.923  Million 2 
Assertio Holdings inc   3,170,226.42 $ 168.022  Million 53 
Cue Health Inc   3,137,837.50 $ 251.027  Million 80 
Horizon Therapeutics Public Limited Company  2,802,652.31 $ 3,643.448  Million 1,300 
Akumin Inc   2,785,288.39 $ 743.672  Million 267 
Marker Therapeutics inc   2,551,141.60 $ 12.756  Million 5 
Shockwave Medical Inc   2,435,154.15 $ 616.094  Million 253 
Arcturus Therapeutics Holdings Inc   2,382,576.58 $ 264.466  Million 111 
Moderna Inc   2,266,808.51 $ 10,654.000  Million 4,700 
Tvardi Therapeutics Inc   2,264,333.33 $ 27.172  Million 12 
Eagle Pharmaceuticals inc   2,201,290.60 $ 257.551  Million 117 
Spero Therapeutics Inc   2,169,280.00 $ 54.232  Million 25 
Sorrento Therapeutics Inc   2,142,333.33 $ 64.270  Million 30 
Novavax inc   2,132,647.53 $ 1,597.353  Million 749 
Semler Scientific inc   2,085,580.65 $ 64.653  Million 31 
Xeris Biopharma Holdings Inc   2,062,661.54 $ 134.073  Million 65 
Amgen Inc   2,044,769.23 $ 26,582.000  Million 13,000 
Siga Technologies Inc  1,995,315.45 $ 97.770  Million 49 
Prestige Consumer Healthcare Inc   1,981,296.49 $ 1,129.339  Million 570 
Seres Therapeutics Inc   1,975,303.03 $ 130.370  Million 66 
Elutia Inc   1,849,384.62 $ 48.084  Million 26 
Kineta Inc   1,832,750.00 $ 7.331  Million 4 
Halozyme Therapeutics Inc   1,828,966.90 $ 773.653  Million 423 
Intra cellular Therapies Inc   1,811,074.26 $ 365.837  Million 202 
Seagen Inc   1,801,667.50 $ 2,162.001  Million 1,200 
Innoviva Inc   1,786,955.97 $ 284.126  Million 159 
Harmony Biosciences Holdings inc   1,702,580.20 $ 498.856  Million 293 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.